A detailed history of Westpac Banking Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, Westpac Banking Corp holds 75,746 shares of NVO stock, worth $5.97 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
75,746
Previous 63,678 18.95%
Holding current value
$5.97 Million
Previous $7.58 Billion 14.07%
% of portfolio
0.43%
Previous 0.51%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$85.0 - $120.04 $1.03 Million - $1.45 Million
12,068 Added 18.95%
75,746 $6.52 Billion
Q3 2024

Nov 07, 2024

BUY
$119.07 - $145.42 $7.58 Million - $9.26 Million
63,678 New
63,678 $7.58 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $178B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Westpac Banking Corp Portfolio

Follow Westpac Banking Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westpac Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Westpac Banking Corp with notifications on news.